Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;28(9):1175-1179.
doi: 10.1002/pds.4839. Epub 2019 Jun 17.

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care

Petra Denig  1 , Eugène P van Puijenbroek  2   3 , Nashwa Soliman  1 , Peter G M Mol  1   4 , Sieta T de Vries  1
Affiliations

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care

Petra Denig et al. Pharmacoepidemiol Drug Saf. 2019 Sep.

Abstract

Purpose: Little is known about adverse drug events (ADEs) experienced over time during chronic drug use. The purpose of this study was to assess ADE patterns experienced by patients with diabetes.

Methods: Patients who received an oral glucose-lowering drug completed a daily diary for 13 weeks. The diary asked for experienced symptoms and whether patients related these symptoms to any drug they used. Summaries of Product Characteristics were used to check whether the ADEs were known adverse drug reactions (ADRs) of the drugs used. Patterns of weekly occurring ADEs were assessed with descriptive statistics.

Results: We included 78 patients. Almost half of them reported at least one ADE (N = 36; 46%). In total, 80 ADEs were reported. Of these ADEs, 71 (90%) were known ADRs. ADEs lasted less than 1 week in 27 cases (34%) and between 2 and 12 weeks in 15 cases (19%). The remaining ADEs fluctuated (16 cases; 20%) or persisted (22 cases; 28%) during the entire study period.

Conclusions: ADEs experienced by patients with diabetes can fluctuate or persist over long periods of drug use.

Keywords: diabetes mellitus; drug-related side effects and adverse reactions; patients; pharmacoepidemiology; primary health care; type 2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. de Vries ST, Haaijer‐Ruskamp FM, de Zeeuw D, Denig P. Construct and concurrent validity of a patient‐reported adverse drug event questionnaire: a cross‐sectional study. Health Qual Life Outcomes. 2014;12(1):103. - PMC - PubMed
    1. de Jong L, Härmark L, van Puijenbroek E. Time course, outcome and management of adverse drug reactions associated with metformin from patient's perspective: a prospective, observational cohort study in the Netherlands. Eur J Clin Pharmacol. 2016;72(5):615‐622. - PubMed
    1. Oosterhuis I, Härmark L, van Puijenbroek E. Experiences with the use of varenicline in daily practice in the Netherlands: a prospective, observational cohort study. Drug Saf. 2014;37(6):449‐457. - PubMed
    1. Härmark L, Puijenbroek E, Grootheest K. Longitudinal monitoring of the safety of drugs by using a web‐based system: the case of pregabalin. Pharmacoepidemiol Drug Saf. 2011;20(6):591‐597. - PubMed
    1. Scholl JH, van de Ven PM, van Puijenbroek EP. Parametric time‐to‐onset models were developed to improve causality assessment of adverse drug reactions from antidiabetic drugs. J Clin Epidemiol. 2015;68(12):1423‐1431. - PubMed

MeSH terms

Substances